Vartan Ghazarossian, president and CEO of StemCor, said: “The grant will be used to broaden our capabilities regarding the harvest of bone marrow, as well as the processing of stem and progenitor cells it contains, for bone marrow transplantation. Additionally, the MarrowMiner System has the potential to improve upon a growing number of therapeutic applications in the field of Regenerative Medicine including cardiovascular, neurologic, diabetic and orthopedic disorders.”